EXCLUSION OF THE 13-KDA RAPAMYCIN BINDING-PROTEIN GENE (FKBP2) AS A CANDIDATE GENE FOR MULTIPLE ENDOCRINE NEOPLASIA TYPE-1

被引:0
|
作者
GRIMMOND, S
WEBER, G
LARSSON, C
WALTERS, M
TEH, B
SHEPHERD, J
NORDENSKJOLD, M
HAYWARD, N
机构
[1] KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN
[2] PRINCESS ALEXANDRA HOSP,DEPT ENDOCRINOL,BRISBANE,QLD,AUSTRALIA
[3] UNIV HOBART,DEPT SURG,HOBART,TAS,AUSTRALIA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The MEN1 gene is considered to be a tumour suppressor gene and has been localised to a 1-Mb region of 11q13.1. In this study, we report the physical localisation of the 13-kDa FK506 and rapamycin binding protein gene (FKBP2) to the cosmid marker D11S750, which is located inside the MEN1 region of non-recombination. The product of this gene is involved in signal transduction and is thus a candidate cell growth regulator or tumour suppressor gene. Northern studies have revealed that FKBP2 is expressed in those tissues predisposed to hyperplasia in MEN1; however, single-strand conformation polymorphism analysis and direct sequencing of DNAs from affected members of MEN1 kindreds and sporadic tumour DNAs have been performed and no mutations have been found. These studies exclude FKBP2 as a candidate gene for MEN1.
引用
收藏
页码:455 / 458
页数:4
相关论文
共 35 条
  • [1] EXCLUSION OF FAU AS THE MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 (MEN1) GENE
    KAS, K
    WEBER, G
    MERREGAERT, J
    MICHIELS, L
    SANDELIN, K
    SKOGSEID, B
    THOMPSON, N
    NORDENSKJOLD, M
    LARSSON, C
    FRIEDMAN, E
    HUMAN MOLECULAR GENETICS, 1993, 2 (04) : 349 - 353
  • [2] HYPERPARATHYROIDISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 - CANDIDATE GENE AND PARATHYROID CALCIUM SENSING PROTEIN EXPRESSION
    CARLING, T
    RASTAD, J
    RIDEFELT, P
    GOBL, A
    HELLMAN, P
    OBERG, K
    RASK, L
    LARSSON, C
    JUHLIN, C
    AKERSTROM, G
    SKOGSEID, B
    SURGERY, 1995, 118 (06) : 924 - 931
  • [3] Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1)
    Lloyd, SE
    Pang, JT
    Pearce, SHS
    Leigh, SEA
    Thakker, RV
    HUMAN GENETICS, 1997, 99 (05) : 585 - 589
  • [4] Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1)
    S. E. Lloyd
    J. T. Pang
    S. H. S. Pearce
    S. E. A. Leigh
    R. V. Thakker
    Human Genetics, 1997, 99 : 585 - 589
  • [5] LOCALIZATION AND IDENTIFICATION OF THE MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 DISEASE GENE
    LARSSON, C
    FRIEDMAN, E
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (01) : 67 - 79
  • [6] FAMILIAL MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 - MUTATION OF A TUMOR SUPPRESSOR GENE
    MARX, SJ
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1989, 1 (02): : 76 - 82
  • [7] Exclusion of the nuclear factor-kappa B3 (REL A) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene
    Landsvater, RM
    deWit, MJ
    Peterson, LF
    Sinke, RJ
    vanKessel, AG
    Lips, CJM
    Hoppener, JWM
    BIOCHEMICAL AND MOLECULAR MEDICINE, 1997, 60 (01) : 76 - 79
  • [8] Exclusion of the phosphatidylinositol-specific phospholipase C beta 3 (PLC beta 3) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene
    deWit, MJ
    Landsvater, RM
    Sinke, RJ
    vanKessel, AG
    Lips, CJM
    Hoppener, JWM
    HUMAN GENETICS, 1997, 99 (01) : 133 - 137
  • [9] MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 GENE MAPS TO CHROMOSOME-11 AND IS LOST IN INSULINOMA
    LARSSON, C
    SKOGSEID, B
    OBERG, K
    NAKAMURA, Y
    NORDENSKJOLD, M
    NATURE, 1988, 332 (6159) : 85 - 87
  • [10] Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1
    Weber, G
    Grimmond, S
    Lagercrantz, J
    Friedman, E
    Phelan, C
    Carson, E
    Hayward, N
    Jacobovitz, O
    Nordenskjold, M
    Larsson, C
    HUMAN GENETICS, 1997, 99 (01) : 130 - 132